Cargando…

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity in persons living with HIV (PLWH) and HIV appears to uniquely cause COPD, independent of smoking. The mechanisms by which HIV leads to COPD are not clear. The objective of this study was to identify metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodgson, Shane, Griffin, Timothy J, Reilly, Cavan, Harvey, Stephen, Witthuhn, Bruce A, Sandri, Brian J, Kunisaki, Ken M, Wendt, Chris H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387954/ https://www.ncbi.nlm.nih.gov/pubmed/28409005 http://dx.doi.org/10.1136/bmjresp-2017-000180

Ejemplares similares

DNA methylation is associated with airflow obstruction in patients living with HIV
por: Hernandez Cordero, Ana I, et al.
Publicado: (2021)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
por: Pavey, Holly, et al.
Publicado: (2023)

Evaluation of ‘care bundles’ for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK
por: Morton, Katherine, et al.
Publicado: (2019)

Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction
por: Arjomandi, Mehrdad, et al.
Publicado: (2018)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
por: Han, Meilan K, et al.
Publicado: (2020)

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England
por: Czira, Alexandrosz, et al.
Publicado: (2022)

Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease—health care utilisation in the subsequent 2 years
por: Walsh, James R, et al.
Publicado: (2019)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
por: Santer, Peter, et al.
Publicado: (2020)

Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease
por: Annangi, Srinadh, et al.
Publicado: (2022)

Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: a scoping review
por: MacDonell, Rachel, et al.
Publicado: (2020)

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD)
por: Arbillaga-Etxarri, Ane, et al.
Publicado: (2017)

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2018)

Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
por: Kusunose, Masaaki, et al.
Publicado: (2017)

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Hitchings, Andrew W, et al.
Publicado: (2016)

Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease
por: Hall, James, et al.
Publicado: (2022)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
por: Vilarinho, Rui, et al.
Publicado: (2022)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Characteristics of inflammatory phenotypes in patients with chronic obstructive pulmonary disease: a cross-sectional study
por: Wen, Xiang, et al.
Publicado: (2023)

Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation and heart failure in community patients with chronic obstructive pulmonary disease
por: Groenewegen, Amy, et al.
Publicado: (2022)

Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease
por: Savage, Charlotte Claire, et al.
Publicado: (2018)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2021)

Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study
por: Zhu, Zheng, et al.
Publicado: (2023)

Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
por: de Broucker, Virginie, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis
por: Sana, Adama, et al.
Publicado: (2018)

Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease
por: Le, Tham Thi, et al.
Publicado: (2020)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

Decreased left ventricular stroke volume is associated with low-grade exercise tolerance in patients with chronic obstructive pulmonary disease
por: Inoue, Sumito, et al.
Publicado: (2017)

Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss
por: Nikolaou, Vasilis, et al.
Publicado: (2021)

Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis
por: Lv, Hongzhen, et al.
Publicado: (2023)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Reasons for Accident and Emergency department attendance by people with chronic obstructive pulmonary disease or heart failure: recipients and providers’ perspectives. An exploratory study
por: Lee, Jeong Su, et al.
Publicado: (2018)

Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China
por: Liu, Sha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uqgia23p7kc23opltt6ch6vfbu